Multiple medical device and digital health companies including Baxter have called for FDA to continue requiring 510(k) premarket notifications for their products in a collection of public comments to proposed regulatory changes.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2025,